PDS Flashcards
Audit cycle
Topic identification – importance Standard setting – using guidelines Data collection – what date is to be collected and whether it will be retrospective or prospective Data analysis Change implementation
Affordability
Some households may have less access to funds through the previous allocation of funds to some unnecessary expenditures such as smoking and alcohol
This may lead to a reduced capacity to be have disposable income to pay for some aspects that could lead to a healthy lifestyle:
Some forms of exercise
Healthy diet
Optimal allocation
Involves deciding what to fund and what not to fund
Equity
Fairness of how resources are allocated
Efficency
Maximising benefits in the face of budgets
Effectiveness
Measured by clinical improvements such as increasing survival or improving QoL
Cost effectiveness analysis
Most common approach used in clinical practise. Increments per surviver compared against previous treatment
Negatives with cost effectiveness analysis
Public health programmes are likely to have multiple components and therefore multiple potentially beneficial (or harmful) outcomes
CEA only focuses on a single outcome dimension
It ignores all other effects and if some of these are important then it is possible that the conclusions drawn will be wrong
Can not compare interventions if the single simple outcome is not common across interventions
Cost utility analysis
Measures, then values the impact of an intervention in terms of improvements in BOTH quantity AND quality of life
Often reported as quality adjusted life years (QALYs)
Allows comparisons to be made across all areas of a health intervention. Reported as cost per QALY gained
QALY
QALYs take into account not only length of life, but also the quality of the life years. Calculated by the increased life span and the QoL improvement a treatment offers
Cost benefit analysis
Values all costs and benefits in monetary units. If benefits exceed costs, the evaluation would recommend investing in the programme and vice versa
Favoured approach by economists working in other areas such as environment, development, and transport for economic evaluation
Negatives of cost benefit analysis
Often just report costs so may ignore benefits or problems with treatment. Difficult to implement into the NHS due to not valuing health via monetary perspective
Incidence
Number of new cases in a given population in a given time period, usually per year or per quarter
Prevelance
Number of people in the population in a given time period who are living with the condition
Susceptible population
Those with no immunity (either through vaccination or acquired). Some populations may be more susceptible than others:
Pregnant women
The very young or very old
Immunocompromised
IVDU
Transmission of infectious diseases
Person to person by inhalation of infected airborne droplets or particles (eg influenza, TB)
Contact with bodily fluids (eg ebola)
Directly from person to person by sexual contact (eg syphilis, HIV)
By ingestion of contaminated food or water (eg salmonella, hepatitis A)
Indirectly through surface or other contamination (eg hepatitis C from contaminated needles, HIV from blood products)
Through an intermediate animal host or vector (eg malaria)